Lopid gemfibrozil: Phase IV results; marketed

Researchers published in The New England Journal of Medicine results from a 5-year, placebo-controlled

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE